It is predicted that the market size of 'gene therapy', a medical technique that modifies an individual's genes to treat ...

Advanz Pharma secures exclusive rights from Alvotech to commercialize three biosimilar candidates in Europe in addition to previously partnered programsThe agreement includes proposed biosimilars to ...

GBAC “Quantum Healthcare 2025” board blueprint—$3.2 B QC drug-discovery market, 42 % CAGR, 50–70 % faster R&D cycles ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

LONDON, GREATER LONDON, UNITED KINGDOM, May 23, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts ...

Samsung Biologics Co., the world’s largest contract drugmaker, will undergo a strategic split to separate its contract ...

Experts say it’s no surprise that UnitedHealthcare often ends up in the crosshairs of public and political scrutiny, as it’s ...

The global menopause treatment market is projected to witness a substantial surge over the next decade, with its value expected to climb from USD 758.5 million in 2024 to USD 1,308.00 million by 2034, ...

Rznomics Inc., a South Korean RNA therapeutics developer, has signed an agreement worth more than $1.3 billion with US pharmaceutical giant Eli Lilly & Co. to license out its novel RNA-editing ...

Report Ocean has published a new report on the Immunotherapy Drugs Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. T ...

Eli Lilly and Company announced today that the Australian Therapeutic Goods Administration (TGA) has granted marketing authorization for Kisunla (donanemab), an injection for intravenous infusion ...

Shares rose in Asia on Wednesday while oil prices jumped more than $1.20 a barrel following a report that Israel may be ...